scispace - formally typeset
S

Sérgio Paulo Bydlowski

Researcher at University of São Paulo

Publications -  28
Citations -  5812

Sérgio Paulo Bydlowski is an academic researcher from University of São Paulo. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 22, co-authored 25 publications receiving 4822 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

DNA tests probe the genomic ancestry of Brazilians

TL;DR: The high individual ancestral variability observed suggests that each Brazilian has a singular proportion of Amerindian, European and African ancestries in his mosaic genome.
Journal ArticleDOI

Synthesis and characterization of a metal complex containing naringin and Cu, and its antioxidant, antimicrobial, antiinflammatory and tumor cell cytotoxicity.

TL;DR: The results of these analyses indicate that the Naringin-Cu (II) complex 1 showed higher antioxidant, anti-inflammatory and tumor cell cytotoxicity activities than free naringin without reducing cell viability.
Journal ArticleDOI

Color and genomic ancestry in Brazilians: a study with forensic microsatellites.

TL;DR: The present investigation based on data from 12 commercially available forensic microsatellites corroborate and validate previous conclusions that in Brazil at the individual level there is significant dissociation of color and genomic ancestry.
Journal ArticleDOI

Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs.

TL;DR: Aside from the substantial benefits that result from the use of various HAART regimens, laboratory and clinical experience has shown that HAART can induce severe and considerable adverse effects related to metabolic complications of lipid metabolism, characterized by signs of lipodystrophy, insulin resistance, central adiposity, dyslipidemia, increased risk of cardiovascular disease and even an increased risk